Gyre Therapeutics (GYRE) EPS (Basic) (2010 - 2026)
Gyre Therapeutics (GYRE) reported EPS (Basic) of -$0.1 for Q1 2026, down 433.33% year-over-year from $0.03 in Q1 2025, and down 400.0% quarter-over-quarter from -$0.02 in Q4 2025.
Gyre Therapeutics (GYRE) EPS (Basic) (2010 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has 17 years of EPS (Basic) data on file, last reported at -$0.1 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.1, down 433.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.08 (down 200.0% YoY), and the FY2025 annual result was $0.06, down 57.14% from the prior year.
- EPS (Basic) slipped to -$0.1 in Q1 2026 per GYRE's latest filing, from -$0.02 in the prior quarter.
- Over five years, EPS (Basic) peaked at $1.64 in Q2 2022 and troughed at -$1.54 in Q4 2023.
- A 5-year average of -$0.09 and a median of $0.01 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) soared 356.25% in 2022, then slumped 1619.09% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$1.28 in 2022, then fell by 20.31% to -$1.54 in 2023, then surged by 99.92% to -$0.0 in 2024, then tumbled by 1619.09% to -$0.02 in 2025, then sank by 400.0% to -$0.1 in 2026.
- Business Quant data shows GYRE's EPS (Basic) at -$0.1 in Q1 2026, -$0.02 in Q4 2025, and $0.04 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn | -0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | -0.02 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | -1.54 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.04 |
| Dec 31, 2022 | -1.28 |
| Sep 30, 2022 | -0.16 |
| Jun 30, 2022 | 1.64 |
| Mar 31, 2022 | -0.46 |
| Dec 31, 2021 | -0.64 |
| Sep 30, 2021 | -0.80 |
| Jun 30, 2021 | -0.64 |